Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial
In the randomized, phase II (part 1) ATTRACTION-4 trial, nivolumab combined with chemotherapy [S-1 plus oxaliplatin (SOX) or capecitabine plus oxaliplatin (CapeOX)]... Read More
Helicobacter pylori status and risks of metachronous recurrence after endoscopic resection of early gastric cancer: a systematic review and meta-analysis
A meta-analysis investigates the relationship between H. pylori status (H. pylori negative, H. pylori eradication and H. pylori persistence) and the development... Read More
Long-term survival after liver metastasectomy in gastric cancer: Systematic review and meta-analysis of prognostic factors
With the liver a common site for gastric cancer recurrence, researchers in Elsevier Connect identified prognostic factors for using hepatectomy (liver removal)... Read More
Endoscopic predictive factors associated with local recurrence after gastric endoscopic submucosal dissection
Scientists via Taylor & Francis find that while rates of local recurrence after endoscopic submucosal dissection (ESD) of gastric lesions are low,... Read More
